What's new

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 52, Status: Authorised

Apr 16, 2025 - 13:29
 0
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 52, Status: Authorised
Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 52, Status: Authorised
Read More

Tags:

Previous Article

BYD SEALION 7 awarded maximum five-star Euro NCAP safety rating

Next Article

Record of data processing activity for video-surveillance (CCTV) system

Related Posts

Human medicines European public assessment report (EPAR): Vueway, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

ICH M11 guideline, clinical study protocol template and technical specifications - Scientific guideline

ICH M11 guideline, clinical study protocol template and...

Mar 18, 2025  0

EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2025, 13:30 (CET) to 14 March 2025, 12:30 (CET)

EMA Veterinary Innovation Day, Online, European Medicin...

Feb 13, 2025  0